# Oral Vitamin D2 for Prevention of COVID-19

> **NCT05673980** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 218 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Vitamin D2
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05673980
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-18
- **Primary completion:** 2023-01-19
- **Final completion:** 2023-02-20
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2023-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05673980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05673980, "Oral Vitamin D2 for Prevention of COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05673980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*